Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 213

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 213
---
 Robert E. Hoffman(7)                            |     |              |      5,411 |     |   |    * |   |
| Craig Tendler, M.D.(8)                          |     |              |          — |     |   |    * |   |
| All Officers and Directors as a group (7 Total) |     |              |  3,210,467 |     |   |  6.3 | % |
| Greater than 5% Stockholders                    |     |              |            |     |   |      |   |
| Vijay Patel(9)                                  |     |              | 12,364,430 |     |   | 22.7 | % |
| Samir Patel(10)                                 |     |              |  3,008,494 |     |   |  5.9 | % |
| Charles Theofilos, M.D.(11)                     |     |              |  2,506,321 |     |   |  5.0 | % |

| * | Represents beneficial ownership of less than 1%. |

| (1) | Except as otherwise indicated, the address of each beneficial owner is c/o TuHURA Biosciences, Inc., 10500 University Center Dr., Suite 110, Tampa, FL 33612. |

| (2) | Consists of (i) 2,323,307 shares of TuHURA common stock and (ii) 469,268 options to purchase TuHURA common stock held directly by Dr. Bianco exercisable within 60 days after July 31, 2025. |

| (3) | Consists of 295,440 options to purchase TuHURA common stock held directly by Mr. Dearborn exercisable within 60 days after July 31, 2025. |

| (4) | Consists of 62,886 options to purchase TuHURA common stock held directly by Mr. Ng exercisable within 60 days after July 31, 2025. |

136

| (5) | Consists of 27,106 options to purchase TuHURA common stock held directly by Dr. List exercisable within 60 days after July 31, 2025. |

| (6) | Consists of 27,106 options to purchase TuHURA common stock held directly by Dr. Manuso exercisable within 60 days after July 31, 2025